The pyrimidinosome: Orchestrating pyrimidine biosynthesis and ferroptosis defense
Molecular Cell · 2023-08 · 83 (16) · 2837-2839
DOI: 10.1016/j.molcel.2023.07.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023-08. Verfasst von Boyi Gan. Beteiligte Einrichtung: Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: bgan@mdanders…. Hauptthemen laut MEDLINE: Ferroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: NCI NIH HHS, National Institutes of Health, University of Texas MD Anderson Cancer Center.
Abstract (Originalsprache)
A recent study by Yang et al.1 uncovers the pyrimidinosome, a multienzyme complex where enzymes from different subcellular compartments collaborate to enable efficient pyrimidine biosynthesis and ferroptosis defense, highlighting the remarkable adaptability of cellular metabolism and new therapeutic opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: bgan@mdanderson.org.
Förderung
- NCI NIH HHS
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
Zitieren
APA
Gan, B. (2023). The pyrimidinosome: Orchestrating pyrimidine biosynthesis and ferroptosis defense. Molecular Cell, 83(16), 2837-2839. https://doi.org/10.1016/j.molcel.2023.07.013
Vancouver
Gan B. The pyrimidinosome: Orchestrating pyrimidine biosynthesis and ferroptosis defense. Molecular Cell. 2023;83(16):2837-2839. doi:10.1016/j.molcel.2023.07.013
BibTeX
@article{Gan2023,
author = {Gan, Boyi},
title = {The pyrimidinosome: Orchestrating pyrimidine biosynthesis and ferroptosis defense},
journal = {Molecular Cell},
year = {2023},
volume = {83},
number = {16},
pages = {2837--2839},
doi = {10.1016/j.molcel.2023.07.013}
}
EUVIMED